Pharma News, Research & Solutions

A preclinical study just published in Nature shows that the company's investigational vaccine has shown positive early data for eliciting an immune response against SARS-CoV-2, the virus that causes COVID-19.

Since the start of the pandemic, Johnson & Johnson has been working to help address the devastating impacts of COVID-19 through the power of its science, the size of its global reach—and the know-how that comes from such experiences as standing up to challenges like HIV.

Through Qualcomm Ventures, we’re seeing wireless technology solutions aimed directly at today’s crucial issues: fighting against COVID-19, better securing our remote work connections, and improving household access to goods and services at scale.

Lisa Ling talks with Dr. Francis Collins, Director, NIH about the latest on treatments and vaccines. Also, Harvard's Dr. Ashish Jha shares how the virus affects the body and Johns Hopkins' Dr. Tom Inglesby explains what the new data on spread means

While the COVID-19 pandemic has created so much uncertainty, we remain committed to supporting people living with substance use disorders and schizophrenia and helping to assure that patients have access to our medicines.

Geoff Martha answers questions about ventilator production, health and safety policies for employees, and more.

Here, at Medtronic, we pride ourselves on getting Further, Together. During this unprecedented time, we will give a new meaning to "togetherness" via healthcare, technology, and communication.

The Biopharma Sustainability Roundtable (BSRT) has partnered with CECP’s CEO Investor Forum to enhance sustainability efforts and focus on long-term value creation. The two groups will co-host the first sector-specific CEO-Investor Forum in June 2021

As the International Aids Society Conference kicks off virtually this year, we sat down with three attendees, including activist and actress Laverne Cox, to talk about their groundbreaking work with HIV/AIDS in the midst of a global pandemic.